John P. Haydek

Gastroenterology

130 Mason Farm Rd
Chapel Hill, NC 27514

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Continued concomitant antibiotic or immunosuppression therapies reduce the risk of pouchitis among patients with ileal pouch-anal anastomosis and primary sclerosing cholangitis.

Continued concomitant antibiotic or immunosuppression therapies reduce the risk of pouchitis among patients with ileal pouch-anal anastomosis and primary sclerosing cholangitis.

Journal: Crohn's & colitis 360

Published: May 19, 2026

Patients With Ileal Pouch-Anal Anastomosis Have Decreased Bowel Frequency on Glucagon-Like Peptide-1 Receptor Agonist Therapy.

Patients With Ileal Pouch-Anal Anastomosis Have Decreased Bowel Frequency on Glucagon-Like Peptide-1 Receptor Agonist Therapy.

Journal: Clinical and translational gastroenterology

Published: March 15, 2026

Inflamed Skin and Bones: SAPHO Syndrome in a Patient with Indeterminate Colitis.

Inflamed Skin and Bones: SAPHO Syndrome in a Patient with Indeterminate Colitis.

Journal: Digestive diseases and sciences

Published: February 24, 2026

AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.

AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.

Journal: Gastroenterology

Published: November 22, 2025

Structural Bowel Disease: Not a Barrier to Transmural Healing With IUS.

Structural Bowel Disease: Not a Barrier to Transmural Healing With IUS.

Journal: Inflammatory bowel diseases

Published: April 29, 2025

Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn's Disease: 2025 AGA Evidence Synthesis.

Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn's Disease: 2025 AGA Evidence Synthesis.

Journal: Gastroenterology

Published: April 24, 2025

Correction to: Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-Analysis.

Correction to: Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-Analysis.

Journal: The American journal of gastroenterology

Published: December 30, 2024

AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis.

AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis.

Journal: Gastroenterology

Published: November 21, 2024

Treat-to-Target Monitoring Adherence and Rates of Healthcare Utilization in Patients With Inflammatory Bowel Disease in a Regional Healthcare System.

Treat-to-Target Monitoring Adherence and Rates of Healthcare Utilization in Patients With Inflammatory Bowel Disease in a Regional Healthcare System.

Journal: Clinical and translational gastroenterology

Published: October 15, 2024

Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-Analysis.

Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-Analysis.

Journal: The American journal of gastroenterology

Published: June 11, 2024

Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis.

Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis.

Journal: Gastroenterology

Published: April 16, 2024

AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders.

AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders.

Journal: Gastroenterology

Published: December 21, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026